IGF2BP3 Antikörper

Produktnummer ABIN969208

Produktdetails anti-IGF2BP3 Antikörper

Target: IGF2BP3 (Insulin-Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser IGF2BP3 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Verwendungszweck: IGF2BP3 Antibody

Aufreinigung: Ascitic fluid

Immunogen: Purified recombinant fragment of human IGF2BP3 expressed in E. Coli.

Klon: 8F11

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: ELISA: 1/10000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Ascitic fluid containing 0.03 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Referenzen für anti-IGF2BP3 Antikörper (ABIN969208)

Sitnikova, Mendese, Liu, Woda, Lu, Dresser, Mohanty, Rock, Jiang: "IMP3 predicts aggressive superficial urothelial carcinoma of the bladder." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, Issue 6, pp. 1701-6, (2008) (PubMed).

Details zu IGF2BP3

Target: IGF2BP3 (Insulin-Like Growth Factor 2 mRNA Binding Protein 3 (IGF2BP3))

Andere Bezeichnung: IGF2BP3 (IGF2BP3 Produkte)

Synonyme: CT98 antikoerper, IMP-3 antikoerper, IMP3 antikoerper, KOC1 antikoerper, VICKZ3 antikoerper, Ab2-255 antikoerper, RGD1306512 antikoerper, imp3 antikoerper, koc1 antikoerper, vera antikoerper, imp-3 antikoerper, vg1rbp antikoerper, vickz3 antikoerper, 2610101N11Rik antikoerper, AA522010 antikoerper, AL022933 antikoerper, AU045931 antikoerper, Koc13 antikoerper, Neilsen antikoerper, mimp3 antikoerper, dvr1rbp antikoerper, wu:fb79c12 antikoerper, wu:fe06h09 antikoerper, zVg1RBP antikoerper, B3 antikoerper, IGF2 mRNA-binding protein 3-B antikoerper, IMP antikoerper, IMP-3-B antikoerper, Vg1 RBP-B antikoerper, Vg1-RBP antikoerper, igf2bp3 antikoerper, igf2bp3-a antikoerper, igf2bp3-b antikoerper, IGF2 mRNA-binding protein 3-A antikoerper, IMP-3-A antikoerper, Vg1 RBP-A antikoerper, vera-A antikoerper, insulin like growth factor 2 mRNA binding protein 3 antikoerper, insulin-like growth factor 2 mRNA binding protein 3 antikoerper, insulin like growth factor 2 mRNA binding protein 3 S homeolog antikoerper, insulin like growth factor 2 mRNA binding protein 3 L homeolog antikoerper, IGF2BP3 antikoerper, Igf2bp3 antikoerper, igf2bp3 antikoerper, igf2bp3.S antikoerper, igf2bp3.L antikoerper

Hintergrund:

Description: The protein encoded by this gene is primarily found in the nucleolus, where it can bind to the 5' UTR of the insulin-like growth factor II leader 3 mRNA and may repress translation of insulin-like growth factor II during late development. The encoded protein contains several KH domains, which are important in RNA binding and are known to be involved in RNA synthesis and metabolism.Tissue specificity: Expressed in fetal liver, fetal lung, fetal kidney, fetal thymus, fetal placenta, fetal follicles of ovary and gonocytes of testis, growing oocytes, spermatogonia and semen (at protein level). Expressed in cervix adenocarcinoma, in testicular, pancreatic and renal-cell carcinomas (at protein level). Expressed ubiquitously during fetal development at 8 and 14 weeks of gestation. Expressed in ovary, testis, brain, placenta, pancreatic cancer tissues and pancreatic cancer cell lines .IMP-3 is a marker for carcinomas and high-grade dysplastic lesions of pancreatic ductal epithelium.

Aliases: CT98, IMP3, KOC1, IMP-3, VICKZ3, DKFZp686F1078, IGF2BP3

Molekulargewicht: 69kDa

Gen-ID: 10643

HGNC: 10643

UniProt: O00425